Impact of Induction Therapy with VRD versus VCD on Outcomes in Patients with Multiple Myeloma in Partial Response or Better Undergoing Upfront Autologous Stem Cell Transplantation.

Impact of Induction Therapy with VRD versus VCD on Outcomes in Patients with Multiple Myeloma in Partial Response or Better Undergoing Upfront Autologous Stem Cell Transplantation. Transplant Cell Ther. 2022 02; 28(2):83.e1-83.e9.

View in: PubMed

subject areas

Antineoplastic Combined Chemotherapy Protocols
Bortezomib
Dexamethasone
Hematopoietic Stem Cell Transplantation
Humans
Induction Chemotherapy
Multiple Myeloma
Transplantation, Autologous

authors with profiles

MUZAFFAR H QAZILBASH